Ratings Moves: ING,...
Health Care: Drugs
Vical Incorporated (VICL: NASDAQ)
$3.50 -0.08 | -2.23%
05/24/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| VICL | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 9.82 | 23.24 | 11.88 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -41.60 | 0.38 | 0.11 |
| Net Income | -0.20 | 0.00 | |
| EPS | -0.56 | 0.00 |
Earnings for VICL:
| EBITDA | -21.00 |
| REVENUE | 17.52M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.11 | $-0.13 | $-0.49 | $-0.51 |
| Number of Analysts | 2 | 2 | 2 | 2 |
| High Estimate | $-0.10 | $-0.13 | $-0.47 | $-0.31 |
| Low Estimate | $-0.12 | $-0.13 | $-0.50 | $-0.71 |
| Prior Year | $-0.09 | $-0.09 | $-0.27 | $-0.49 |
| Growth Rate (Year over Year) | -22.22% | -44.44% | -79.63% | -5.15% |
Portfolios with VICL
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor22 Biopharma Stocks With Br...
- UserO4 Investing
- ContributorStocks With Big Insider Buy...
- Contributor10 Best-Performing Stocks U...
- ContributorRelative Strength Stocks 09...
- ContributorCancer Drug Stocks to Trade...
- ContributorBreakout Stocks Of The Week...
- ContributorDollar Store
Latest VICL Headlines from TheStreet
- 6 Stocks Under $10 Spiking Higher 04.04.13 | 03:04 pm
- 16 Stocks Under $5 Trading At Discounts To Target Price 03.26.13 | 12:03 pm
- Vical To Present At March Investor Conferences 02.27.13 | 06:02 am
- Vical Reports 2012 Financial Results And Progress In Key Development Programs 02.06.13 | 06:02 am
- Vical To Present At February Investor Conferences 02.05.13 | 06:02 am
- Vical Announces Publication Of Herpes Simplex Vaccine Guinea Pig Study Data 02.04.13 | 06:02 am
- Vical Announces News Release And Conference Call Schedule For 2012 Financial Results 01.30.13 | 06:01 am
- 3 Pharma Stocks Under $5 Trading Higher 01.15.13 | 02:01 pm
- Vical To Present At 31st Annual J.P. Morgan Healthcare Conference 01.03.13 | 06:01 am
- Vical Named To NASDAQ Global Select Market 01.02.13 | 06:01 am
Press Releases for VICL
- MERIAL Receives Full License Approval For ONCEPT(TM) Canine Melanoma Vaccine - PR Newswire 02.16.10 | 08:02 am
Partner Headlines for VICL
- Vical and Bristol-Myers Ink Deal - Analyst Blog - NASDAQ 09.17.12 | 07:09 pm
- Abbott-Astellas Collaborate - Analyst Blog - NASDAQ 09.13.12 | 10:09 pm
- Abbott-Astellas Collaborate - Analyst Blog - Zacks 09.13.12 | 06:09 pm
- 3 Vaccine Companies With Upcoming Catalysts - Seeking Alpha 09.09.12 | 08:09 am
- 3 Speculative Biotechs Worth Watching - Seeking Alpha 07.08.12 | 08:07 am
- Vical Back On The Move - Seeking Alpha 11.04.11 | 06:11 pm
- Vical: Making Progress In The Area Of HSV-2 Vaccines - Seeking Alpha 08.26.11 | 10:08 pm
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.15.11 | 06:07 pm
- Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward - Seeking Alpha 03.29.11 | 08:03 am
- Ipilimumab Approval Highlights Active Immunotherapy Renaissance - Seeking Alpha 03.27.11 | 08:03 am
